4-HO-DALT
外觀
| 臨床資料 | |
|---|---|
| 其他名稱 | 4-Hydroxy-N,N-diallyltryptamine; 4-Hydroxy-DALT; 4-OH-DALT; Dalocin |
| 藥物類別 | Serotonin receptor agonist; Serotonergic psychedelic; Hallucinogen |
| ATC碼 |
|
| 識別資訊 | |
| |
| CAS號 | 2173386-70-2 |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 化學資訊 | |
| 化學式 | C16H20N2O |
| 摩爾質量 | 256.35 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
4-HO-DALT(4-羥基-N,N-二烯丙基色胺,英語:4-hydroxy-N,N-diallyltryptamine)是一種色胺衍生物,化學式為C16H20N2O,可作為迷幻藥物,最早由亞歷山大·舒爾金在1997年的書《TiHKAL》中描述[1]。
參考文獻
[編輯]- ^ CiteTiHKAL: "Another direction possible for modifying the structure would be to relocate the oxygen in indole ring over to the 4-position. 4-Methoxytryptamine is commercially available, and it should be directly substitutable for the 5-methoxytryptamine used in this synthetic process giving rise to 4-MeO-DALT. Yet further out, what about starting the 4-benzyloxytryptamine and walking the same path? The product could be easily stripped of the benzyl ether by the usual catalytic hydrogenation, giving rise to the diallyl analogue of psilocin, 4-HO-DALT. I would wager a ten dollar bet that the acetate ester of this material, 4-AcO-DALT would be in the brain within minutes of swallowing the pill."